BioCentury
ARTICLE | Financial News

Kosan raises $25 million

March 31, 2006 2:25 AM UTC

KOSN raised $25 million through the sale of 5 million shares at $5 in a follow-on underwritten by Credit Suisse and Cowen. The company has two compounds in Phase II testing for breast cancer: KOS-862,...